glp-1 and breast cancer risk Receptor Agonists Show a Striking Signal in Outcomes, but Big Questions Remain GLP-1 use linked to lower
Description
Levin PA, Wei W, Zhou S, Xie L, Baser O
El uso de los aGLP-1 est recomendado cuando existe un "condicionante clnico predominante"
Compared with DPP-4i users, GLP-1 RA users were younger (mean age 56.1 vs 62.3 years), had a higher body mass index (36.5 vs 32.1 kg/m), and were less likely to be male (45.2% vs 50.4%)
When combined with information about your antidepressant use, genetic testing helps PlexusDx create a truly personalized weight loss strategy that accounts for your mental health medications and individual metabolic response
Your clinician will screen for risks and contraindications
Be patient with cosmetic changes
